United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News MPS Limited (NSE: MPSLTD) acquires Unbound Medicine to deepen platform expansion into AI-powered healthcare learning MPS Limited acquires Unbound Medicine for $16.5M, entering AI-driven healthcare learning. Find out what this strategic pivot means for its platform future. byVenkateshJanuary 31, 2026